# A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

> **NCT00542685** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 551 (actual)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DRUG:** PD 0332334
- **DRUG:** Placebo
- **DRUG:** PD 0332334
- **DRUG:** PD 0332334

## Key facts

- **NCT ID:** NCT00542685
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 551 (ACTUAL)
- **Last updated:** 2012-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00542685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00542685, "A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00542685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*